Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2005 Annual Meeting | Stroke Prevention in 2005

Sunday 04/10/05
09:00 AM - 12:45 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
AM Half-Day Course
Mitchell S. Elkind, MD, MS, FÂ鶹´«Ã½Ó³»­
Cerebrovascular Disease and Interventional Neurology
Upon completion:
Participants should be able to discuss and apply to patient care the latest clinical trial results regarding antithrombotic agents in stroke prevention, including aspirin, clopidogrel, dipyridamole, warfarin, and ximelagatran; discuss evidence linking inflammatory markers like high sensitivity C-reactive protein to risk of stroke; use markers of inflammation appropriately in the evaluation of stroke patients; decide how to use statin therapy in stroke patients; provide a rational approach to the medical management of patients with patent foramen ovale; interpret the data on PFO closure; and discuss the results of recent trials of carotid surgery and stenting.
No CME available
Advanced
Practitioner, Fellow, Academician, Resident
Event Timeline
09:00 AM - 09:45 AM The Current Science of Anti-Thrombotic Therapy
Oscar R. Benavente, MD, FRCP(C)
09:45 AM - 10:30 AM Lipoproteins, C-Reactive Protein and Inflammation: A Statin for Every Stroke Patient?
Mitchell S. Elkind, MD, MS, FÂ鶹´«Ã½Ó³»­
10:30 AM - 10:45 AM Break
10:45 AM - 11:30 AM Patent Foramen Ovale: To Close or Not to Close?
Karen L. Furie, MD
11:30 AM - 12:15 PM Carotid Endarterectomy and Stenting: When to Use Which
Pierre Fayad, MD, FAHA, FÂ鶹´«Ã½Ó³»­
12:15 PM - 12:45 PM Questions and Answers
Faculty Disclosures
Mitchell S. Elkind, MD, MS, FÂ鶹´«Ã½Ó³»­ Dr. Elkind has received personal compensation for serving as an employee of American Heart Association. Dr. Elkind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Atria Academy.
Pierre Fayad, MD, FAHA, FÂ鶹´«Ã½Ó³»­ Dr. Fayad has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Fayad has received personal compensation in the range of $0-$499 for serving as a Member Data Safety & Monitoring Committee with NINDS.
Oscar R. Benavente, MD, FRCP(C) No disclosure on file
Karen L. Furie, MD The institution of Dr. Furie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/BMS. Dr. Furie has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ/JNNP. The institution of Dr. Furie has received research support from NINDS.